Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Thymalfasin

EU orphan designation number: EU/3/02/110   
Active ingredient: Thymalfasin
Indication: Treatment of hepatocellular carcinoma
Sponsor: SciClone Pharmaceuticals Italy S.r.l
Via Lisbona 11, I-00198 Roma, Italia

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/07/2002 Centralised Orphan - Designation EMEA/OD/015/02 (2002)3017 of 30/07/2002